![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 18251 |
FusionGeneSummary for KCNE2_HTN3 |
![]() |
Fusion gene information | Fusion gene name: KCNE2_HTN3 | Fusion gene ID: 18251 | Hgene | Tgene | Gene symbol | KCNE2 | HTN3 | Gene ID | 9992 | 3347 |
Gene name | potassium voltage-gated channel subfamily E regulatory subunit 2 | histatin 3 | |
Synonyms | ATFB4|LQT5|LQT6|MIRP1 | HIS2|HTN2|HTN5 | |
Cytomap | 21q22.11 | 4q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | potassium voltage-gated channel subfamily E member 2cardiac voltage-gated potassium channel accessory subunit 2minK-related peptide-1minimum potassium ion channel-related peptide 1potassium channel subunit beta MiRP1potassium channel subunit, MiRP1p | histatin-3PBbasic histidine-rich proteinhistatin-4histatin-5histatin-6histatin-7histatin-8histatin-9histidine-rich protein 3hst | |
Modification date | 20180522 | 20180519 | |
UniProtAcc | Q9Y6J6 | P15516 | |
Ensembl transtripts involved in fusion gene | ENST00000290310, | ENST00000526767, ENST00000530128, ENST00000381057, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 4 X 4 X 2=32 |
# samples | 1 | 4 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: KCNE2 [Title/Abstract] AND HTN3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KCNE2 | GO:0035690 | cellular response to drug | 10219239 |
Hgene | KCNE2 | GO:0060306 | regulation of membrane repolarization | 10219239 |
Hgene | KCNE2 | GO:0071435 | potassium ion export | 10219239 |
Hgene | KCNE2 | GO:0071805 | potassium ion transmembrane transport | 10219239 |
Hgene | KCNE2 | GO:0086009 | membrane repolarization | 10219239 |
Hgene | KCNE2 | GO:1901379 | regulation of potassium ion transmembrane transport | 10219239 |
Hgene | KCNE2 | GO:1901800 | positive regulation of proteasomal protein catabolic process | 22180649 |
Hgene | KCNE2 | GO:1901979 | regulation of inward rectifier potassium channel activity | 10219239 |
Hgene | KCNE2 | GO:1902259 | regulation of delayed rectifier potassium channel activity | 10219239 |
Hgene | KCNE2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity | 19219384 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-A8-A06U-01A | KCNE2 | chr21 | 35736450 | + | HTN3 | chr4 | 70898884 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000290310 | ENST00000526767 | KCNE2 | chr21 | 35736450 | + | HTN3 | chr4 | 70898884 | + |
5UTR-3CDS | ENST00000290310 | ENST00000530128 | KCNE2 | chr21 | 35736450 | + | HTN3 | chr4 | 70898884 | + |
5UTR-3CDS | ENST00000290310 | ENST00000381057 | KCNE2 | chr21 | 35736450 | + | HTN3 | chr4 | 70898884 | + |
Top |
FusionProtFeatures for KCNE2_HTN3 |
![]() |
Hgene | Tgene |
KCNE2 | HTN3 |
Ancillary protein that assembles as a beta subunit witha voltage-gated potassium channel complex of pore-forming alphasubunits. Modulates the gating kinetics and enhances stability ofthe channel complex. Assembled with KCNB1 modulates the gatingcharacteristics of the delayed rectifier voltage-dependentpotassium channel KCNB1. Associated with KCNH2/HERG is proposed toform the rapidly activating component of the delayed rectifyingpotassium current in heart (IKr). May associate with KCNQ2 and/orKCNQ3 and modulate the native M-type current. May associate withHCN1 and HCN2 and increase potassium current. Interacts withKCNQ1; forms a heterooligomer complex leading to currents with anapparently instantaneous activation, a rapid deactivation processand a linear current-voltage relationship and decreases theamplitude of the outward current (PubMed:11101505).{ECO:0000250|UniProtKB:P63161, ECO:0000269|PubMed:10219239,ECO:0000269|PubMed:11101505}. | Histatins are salivary proteins that are considered tobe major precursors of the protective proteinaceous structure ontooth surfaces (enamel pellicle). In addition, histatins exhibitantibacterial and antifungal activities. His3-(20-43)-peptide(histatin-5) is especially effective against C.albicans andC.neoformans, and inhibits Lys-gingipain and Arg-gingipain (rgpB)from P.gingivalis. In addition, His3-(20-43)-peptide is a potentinhibitor of metalloproteinases MMP2 and MMP9.{ECO:0000269|PubMed:11179305, ECO:0000269|PubMed:8945538}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KCNE2_HTN3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KCNE2_HTN3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
KCNE2 | KCNQ1, ATP4A, CACNA1C | HTN3 | HSPA8 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KCNE2_HTN3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for KCNE2_HTN3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KCNE2 | C3150953 | Long Qt Syndrome 6 | 4 | CTD_human;UNIPROT |
Hgene | KCNE2 | C0023976 | Long QT Syndrome | 3 | CTD_human |
Hgene | KCNE2 | C0004238 | Atrial Fibrillation | 1 | CTD_human;HPO |
Hgene | KCNE2 | C0042510 | Ventricular Fibrillation | 1 | CTD_human;HPO |
Hgene | KCNE2 | C1862394 | Atrial Fibrillation, Familial, 4 | 1 | CTD_human;UNIPROT |